Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
Healthcare
$18.31 +0.58%
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
52W Low $14.85High $23.00
Volume 0.68M
Average 0.41M
SPTX Other Financing Activities
Financing cash flows not reported separately.
No reported Other Financing Activities figures are available to summarize.
Other Financing Activities history
Currency unavailable · from the cash flow
No Other Financing Activities data reported for this period type.
Other Financing Activities vs competitors
How SPTX compares with its peers on the latest reported figures
SPTX Competitors
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
LBRXLB Pharmaceuticals Inc Common Stock | LTM Mar 2026 | $303.49M USD | — | — | — |
NMRANeumora Therapeutics, Inc. Common Stock | LTM Mar 2026 | $19.65M USD | +476.3% | — | — |
| LTM Mar 2026 | $12.47M USD | +463.5% | — | — | |
| LTM Mar 2026 | $5.6M USD | -38.7% | — | — | |
RAPPRapport Therapeutics, Inc. Common Stock | LTM Mar 2026 | $210K USD | -174.2% | — | 1.1% |
CTNMContineum Therapeutics, Inc. Class A Common Stock | LTM Mar 2026 | $104K USD | +333.3% | — | — |
| LTM Mar 2026 | $0 USD | +100.0% | — | 0.0% | |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding SPTX) | — | +216.7% | — | 0.5% | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Currency unavailable
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.